Trial design and oversight
This is a randomized, controlled, multicenter, open-label, perioperative study of vorasidenib and ivosidenib in recurrent, nonenhancing mThe study was conducted according to the International Council on Harmonisation of Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. All patients provided written informed consent before screening and enrollment.